Literature DB >> 20658998

The ground state of pluripotency.

Jason Wray1, Tuzer Kalkan, Austin G Smith.   

Abstract

Pluripotency is defined as the capacity of individual cells to initiate all lineages of the mature organism in response to signals from the embryo or cell culture environment. A pluripotent cell has no predetermined programme; it is a blank slate. This is the foundation of mammalian development and of ES (embryonic stem) cell biology. What are the design principles of this naïve cell state? How is pluripotency acquired and maintained? Suppressing activation of ERKs (extracellular-signal-regulated kinases) is critical to establishing and sustaining ES cells. Inhibition of GSK3 (glycogen synthase kinase 3) reinforces this effect. We review the effect of selective kinase inhibitors on pluripotent cells and consider how these effects are mediated. We propose that ES cells represent a ground state, meaning a basal proliferative state that is free of epigenetic restriction and has minimal requirements for extrinsic stimuli. The stability of this state is reflected in the homogeneity of ES cell populations cultured in the presence of small-molecule inhibitors of MEK (mitogen-activated protein kinase/ERK kinase) and GSK3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658998     DOI: 10.1042/BST0381027

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  152 in total

1.  Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiation.

Authors:  Xiaofeng Zheng; Raluca Dumitru; Brad L Lackford; Johannes M Freudenberg; Ajeet P Singh; Trevor K Archer; Raja Jothi; Guang Hu
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

2.  The RNA exosome contributes to gene expression regulation during stem cell differentiation.

Authors:  Marta Lloret-Llinares; Evdoxia Karadoulama; Yun Chen; Luke A Wojenski; Geno J Villafano; Jette Bornholdt; Robin Andersson; Leighton Core; Albin Sandelin; Torben Heick Jensen
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

3.  Regulation of Kit Expression in Early Mouse Embryos and ES Cells.

Authors:  Federica Todaro; Federica Campolo; Florencia Barrios; Manuela Pellegrini; Silvia Di Cesare; Lino Tessarollo; Pellegrino Rossi; Emmanuele A Jannini; Susanna Dolci
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

Review 4.  Systems biology of stem cells: three useful perspectives to help overcome the paradigm of linear pathways.

Authors:  Sui Huang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

5.  Inhibition of transforming growth factor β (TGF-β) signaling can substitute for Oct4 protein in reprogramming and maintain pluripotency.

Authors:  Fangzhi Tan; Cheng Qian; Ke Tang; Saber Mohamed Abd-Allah; Naihe Jing
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

6.  Dppa3 is critical for Lin28a-regulated ES cells naïve-primed state conversion.

Authors:  Hui Sang; Dan Wang; Shuang Zhao; Jinxin Zhang; Yan Zhang; Jia Xu; Xiaoniao Chen; Yan Nie; Kaiyue Zhang; Shuaiqiang Zhang; Yuebing Wang; Na Wang; Fengxia Ma; Ling Shuai; Zongjin Li; Na Liu
Journal:  J Mol Cell Biol       Date:  2019-06-01       Impact factor: 6.216

Review 7.  Dgcr8 knockout approaches to understand microRNA functions in vitro and in vivo.

Authors:  Wen-Ting Guo; Yangming Wang
Journal:  Cell Mol Life Sci       Date:  2019-01-29       Impact factor: 9.261

Review 8.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

Review 9.  Signaling networks in human pluripotent stem cells.

Authors:  Stephen Dalton
Journal:  Curr Opin Cell Biol       Date:  2012-10-22       Impact factor: 8.382

Review 10.  Protein kinases and associated pathways in pluripotent state and lineage differentiation.

Authors:  Melina Shoni; Kathy O Lui; Demetrios G Vavvas; Michael G Muto; Ross S Berkowitz; Nikolaos Vlahos; Shu-Wing Ng
Journal:  Curr Stem Cell Res Ther       Date:  2014       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.